Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

1.295 -0.185 (-12.50%)
Streaming Delayed Price Updated: 2:37 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,379,309
Open 1.490
Bid (Size) 1.290 (124)
Ask (Size) 1.300 (10)
Prev. Close 1.480
Today's Range 1.290 - 1.510
52wk Range 1.460 - 19.54
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MacroGenics (MGNX) Q4 2024 Earnings Call Transcript
MGNX earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial

Performance

YTD
-60.8%
-60.8%
1 Month
-49.0%
-49.0%
3 Month
-60.3%
-60.3%
6 Month
-57.4%
-57.4%
1 Year
-91.3%
-91.3%

More News

Read More
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights
Via Benzinga
Macrogenics Earnings Preview
Via Benzinga
Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
MacroGenics Announces Leadership Transition
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
From TerSera Therapeutics LLC
Via Business Wire
MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action – MGNX
From The Rosen Law Firm PA
Via GlobeNewswire
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics
From Faruqi & Faruqi LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire

Frequently Asked Questions

Is MacroGenics, Inc. - Common Stock publicly traded?
Yes, MacroGenics, Inc. - Common Stock is publicly traded.
What exchange does MacroGenics, Inc. - Common Stock trade on?
MacroGenics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MacroGenics, Inc. - Common Stock?
The ticker symbol for MacroGenics, Inc. - Common Stock is MGNX on the Nasdaq Stock Market
What is the current price of MacroGenics, Inc. - Common Stock?
The current price of MacroGenics, Inc. - Common Stock is 1.295
When was MacroGenics, Inc. - Common Stock last traded?
The last trade of MacroGenics, Inc. - Common Stock was at 03/28/25 02:37 PM ET
What is the market capitalization of MacroGenics, Inc. - Common Stock?
The market capitalization of MacroGenics, Inc. - Common Stock is 79.13M
How many shares of MacroGenics, Inc. - Common Stock are outstanding?
MacroGenics, Inc. - Common Stock has 79M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.